2025-07-26 - Analysis Report
Okay, here's an analysis of Starbucks (SBUX) based on the provided data, formatted as a concise report:

## Starbucks Corp (SBUX) Analysis

**Company Overview:** Starbucks Corporation is a global coffeehouse company and roaster of specialty coffees.

**1. Performance vs. S&P 500 (VOO):**

*   **Cumulative Return (SBUX):** 21.27%
*   **Cumulative Return (VOO):** 99.66%
*   **Absolute Divergence:** -74.8%
*   **Relative Divergence:** 17.7% (SBUX's performance is in the 17.7th percentile of its historical divergence range from VOO).

**Alpha, Beta Analysis:**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | -2.0% | 57.8% | -31.0% | -0.0 | 65.3 |
| 2016-2018  | 0.0% | 59.1% | -18.0% | -0.0 | 73.2 |
| 2017-2019  | 50.0% | 59.1% | 21.0% | 1.1 | 99.9 |
| 2018-2020  | 57.0% | 61.7% | 38.0% | 1.4 | 121.6 |
| 2019-2021  | 47.0% | 61.7% | -1.0% | 1.4 | 132.9 |
| 2020-2022  | -28.0% | 66.9% | -31.0% | 1.6 | 112.7 |
| 2021-2023  | -30.0% | 66.9% | -48.0% | 2.5 | 109.1 |
| 2022-2024  | -33.0% | 66.9% | -58.0% | 2.8 | 103.7 |
| 2023-2025  | 0.0% | 69.0% | -52.0% | 4.6 | 107.3 |

*   **Analysis:** SBUX has significantly underperformed the S&P 500. Recent periods show negative alpha and high beta, suggesting underperformance relative to the market with increased volatility. The company experienced substantial growth in market capitalization until recently, which has plateaued.

**2. Recent Stock Price Movements:**

*   **Current Price:** $94.42
*   **Previous Close:** $93.70
*   **Change:** +$0.77
*   **5-Day Moving Average:** $94.73
*   **20-Day Moving Average:** $94.01
*   **60-Day Moving Average:** $89.50

*   **Analysis:** The stock is currently trading above its 20-day and 60-day moving averages, but slightly below its 5-day moving average, indicating a potential short-term consolidation or pullback after a recent upward trend. The positive change from the previous close suggests some upward momentum.

**3. Market Risk Indicators:**

*   **Market Risk Indicator (MRI):** 0.33 (Low Risk)
*   **RSI:** 52.59 (Neutral)
*   **PPO:** -0.15 (Slightly Oversold)
*   **Hybrid Signal:** "cash\_70%\_Sell 0.2% of holdings" (Cautious Signal)
*   **Recent Relative Divergence Change (20-day):** -0.2 (Short-term Downward Trend)
*   **Expected Return:** -203.7% (Long-Term Underperformance vs. S&P 500)

*   **Analysis:**  The low MRI suggests a relatively stable market environment. The neutral RSI and slightly oversold PPO don't provide strong buy or sell signals. The Hybrid Signal suggests a cautious approach. The significant negative expected return is a major concern, implying a potential for significant long-term underperformance compared to the S&P 500. The recent price change indicates the upward momentum.

**4. Recent News & Significant Events:**

*   **Volatility:** SBUX has shown notable volatility.
*   **Analyst Discussions:** Analysts are discussing SBUX's recent performance and outlook.
*   **Business Developments:** SBUX has recent major business developments or regulatory changes.
*   **Risk & Opportunities:** Market experts are highlighting both risks and opportunities.

*   **Analysis:** The news suggests SBUX is facing significant events impacting its stock, warranting investor caution. Keep monitoring the news and events.

**5. Recent Earnings Analysis:**

| 날짜       | EPS  | 매출       |
|------------|------|------------|
| 2025-04-29 | 0.34 | 8.76 B$    |
| 2025-01-28 | 0.69 | 9.40 B$    |
| 2024-07-30 | 0.93 | 9.11 B$    |
| 2024-04-30 | 0.68 | 8.56 B$    |
| 2025-04-29 | 0.68 | 8.56 B$    |

*   **Analysis:** EPS and revenue have fluctuated. The most recent EPS is lower than previous quarters, while revenue shows mixed results. The numbers of 2025-04-29 are duplicate.

**6. Financial Information:**

Revenue and Profitability:

| Quarter    | Revenue    | Profit Margin |
|------------|------------|---------------|
| 2025-03-31 | $8.76B     | 21.09%        |
| 2024-12-31 | $9.40B     | 24.49%        |
| 2024-09-30 | $9.07B     | 26.25%        |
| 2024-06-30 | $9.11B     | 27.91%        |
| 2024-03-31 | $8.56B     | 25.58%        |

Capital and Profitability:

| Quarter    | Equity     | ROE      |
|------------|------------|----------|
| 2025-03-31 | $-7.62B    | -5.04%   |
| 2024-12-31 | $-7.47B    | -10.45%  |
| 2024-09-30 | $-7.45B    | -12.21%  |
| 2024-06-30 | $-7.95B    | -13.28%  |
| 2024-03-31 | $-8.45B    | -9.14%   |

*   **Analysis:** Revenue has generally been positive, although the most recent quarter saw a decline. Profit margins have also decreased in the most recent quarter. The negative equity and negative ROE indicate significant financial challenges and potential solvency concerns.

**7. 종합적인 분석 (Overall Analysis):**

Based on the provided data, Starbucks (SBUX) presents a mixed picture. While the stock price is currently showing some upward momentum, several factors raise concerns:

*   **Significant Underperformance:**  SBUX has significantly underperformed the S&P 500, with a substantial negative expected return.
*   **High Volatility:** The stock exhibits high volatility.
*   **Decreasing Financial Performance:** Recent earnings show mixed results, with a decline in EPS and Revenue in the most recent quarter. Furthermore, declining profit margins and negative equity/ROE indicate fundamental financial weakness.
*   **Cautious Signals:** The Hybrid Signal recommends a cautious investment approach.
*   **Recent News:** The news suggests SBUX is undergoing significant changes, potentially creating uncertainty.

**Conclusion:** Given the underperformance, high volatility, declining financial metrics, and cautious market signals, a **cautious** or **avoidant** approach to SBUX might be warranted. Investors should carefully monitor the company's financial performance, news releases, and analyst reports before making any investment decisions. The negative equity and ROE are particularly concerning and require further investigation.
